TABLE 1

Clinical characteristics of patients with Vα2.3+ T-cells >10.5% in bronchoalveolar lavage fluid (BALF)

LSNon-LS
Subjects18068
Male/female111/6941/27
Age years#37 (21–62)45 (26–72)
Radiographic stage 0/I/II/III/IV#0/123/57/0/04/16/36/8/4
Resolving/non-resolving#166/1425/43
CD4/CD8 ratio*9.8 (0.9–56.8)7.1 (1.2–24.0)
% Vα2.3 BALF cells#28.4 (11.0–50.0)17.8 (11.4–44.3)
HLA-DRB1*03+/155/2536/32
Vα2.3 BALF cells %
 HLA-DRB1*03+#29.920.5
 HLA-DRB1*03**19.814.8
Patients recovered %
 HLA-DRB1*03+#9439
 HLA-DRB1*03**8034

Data are presented as n or mean (range), unless otherwise stated. LS: Löfgreńs syndrome. *: p<0.05, **: p<0.001 and #: p<0.0001, comparing differences between patients with LS and non-LS and for radiological stage differences between stage I and II.